Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
Division of Cardiology, University Hospital "P. Giaccone", Palermo, Italy.
Catheter Cardiovasc Interv. 2023 Nov;102(5):864-877. doi: 10.1002/ccd.30827. Epub 2023 Sep 5.
The recent development and widespread adoption of antegrade dissection re-entry (ADR) techniques have been underlined as one of the antegrade strategies in all worldwide CTO consensus documents. However, historical wire-based ADR experience has suffered from disappointing long-term outcomes.
Compare technical success, procedural success, and long-term outcome of patients who underwent wire-based ADR technique versus antegrade wiring (AW).
One thousand seven hundred and ten patients, from the prospective European Registry of Chronic Total Occlusions (ERCTO), underwent 1806 CTO procedures between January 2018 and December 2021, at 13 high-volume ADR centers. Among all 1806 lesions attempted by the antegrade approach, 72% were approached with AW techniques and 28% with wire-based ADR techniques.
Technical and procedural success rates were lower in wire-based ADR than in AW (90.3% vs. 96.4%, p < 0.001; 87.7% vs. 95.4%, p < 0.001, respectively); however, wire-based ADR was used successfully more often in complex lesions as compared to AW (p = 0.017). Wire-based ADR was used in most cases (85%) after failure of AW or retrograde procedures. At a mean clinical follow-up of 21 ± 15 months, major adverse cardiac and cerebrovascular events (MACCEs) did not differ between AW and wire-based ADR (12% vs. 15.1%, p = 0.106); both AW and wire-based ADR procedures were associated with significant symptom improvements.
As compared to AW, wire-based ADR is a reliable and effective strategy successfully used in more complex lesions and often after the failure of other techniques. At long-term follow-up, patient's MACCEs and symptoms improvement were similar in both antegrade techniques.
最近,正向夹层再进入(ADR)技术的发展和广泛采用已被强调为所有全球 CTO 共识文件中的一种正向策略。然而,基于导丝的 ADR 技术在历史上的经验却遭受了令人失望的长期结果。
比较采用基于导丝的 ADR 技术与正向导丝(AW)技术的患者的技术成功率、手术成功率和长期结果。
在 2018 年 1 月至 2021 年 12 月期间,来自前瞻性的欧洲慢性完全闭塞(CTO)注册研究(ERCTO)的 1710 名患者在 13 个高容量 ADR 中心接受了 1806 例 CTO 手术。在所有通过正向方法尝试的 1806 个病变中,72%采用 AW 技术,28%采用基于导丝的 ADR 技术。
基于导丝的 ADR 的技术和手术成功率低于 AW(90.3%对 96.4%,p<0.001;87.7%对 95.4%,p<0.001);然而,与 AW 相比,基于导丝的 ADR 更常成功用于复杂病变(p=0.017)。在 AW 或逆行手术失败后,85%的情况下使用基于导丝的 ADR。在平均 21±15 个月的临床随访中,AW 和基于导丝的 ADR 之间的主要不良心脑血管事件(MACCE)没有差异(12%对 15.1%,p=0.106);AW 和基于导丝的 ADR 手术均与显著的症状改善相关。
与 AW 相比,基于导丝的 ADR 是一种可靠且有效的策略,在更复杂的病变中成功应用,并且通常在其他技术失败后使用。在长期随访中,两种正向技术的患者 MACCE 和症状改善相似。